Skip to main content

BSN Writing Services

BSN Writing Services

Call Us

+1-(612) 208-2686

Our Email

contact@bsnwritingservices.com

POLI 330N Cover Letter – Week 7 Assignment: Final Project – Policy Issue

POLI 330N Cover Letter – Week 7 Assignment: Final Project – Policy Issue

Student Name

Chamberlain University

POLI-330: Political Science

Prof. Name

Date

Executive Summary

The current analysis centers on a pressing public health concern: the growing substance use crisis across the United States, particularly involving opioids and stimulants. This analysis evaluates The Comprehensive Addiction Resources Emergency (CARE) Act of 2021 (H.R. 6311), a legislative proposal aimed at alleviating the crisis by providing direct federal funding to affected regions. The bill seeks to allocate $100 billion over ten years to support prevention, treatment, and recovery programs for substance use disorders. Organizations such as Mile High Behavioral Healthcare (MHBHC) in Denver, Colorado, could benefit significantly from this initiative, as they provide evidence-based treatment and support services to individuals and families impacted by addiction.

Background

What is The Comprehensive Addiction Resources Emergency Act of 2021?

Introduced in December 2021, H.R. 6311 is a legislative proposal aimed at delivering emergency financial aid to local governments, tribal nations, and nonprofit service providers working to combat substance use disorders (Congress.gov, 2022). The bill focuses specifically on aiding communities most severely impacted by opioid and stimulant misuse. It proposes investing $100 billion over a decade to bolster treatment accessibility, promote cost-effective service delivery, and enhance systemic coordination among addiction service providers.

For example, Colorado, a state heavily affected by the opioid crisis, recorded 543 opioid-related fatalities in 2018, largely driven by substances like fentanyl (CDHS, 2022). Organizations such as MHBHC stand to benefit from the increased funding through expanded resources for Medication-Assisted Treatment (MAT) and dual-diagnosis programs.

Events

What key events have shaped the legislative landscape?

The opioid epidemic has escalated to a public health emergency, exacerbated by the proliferation of synthetic opioids like fentanyl. In response, the CARE Act aims to empower treatment organizations with funding to deliver cost-effective and inclusive care. Several complementary bills have also been introduced, focusing on prevention, data collection, and prescribing practices. However, H.R. 6311 is unique in offering direct funding.

Comparative Legislation Overview

LegislationPrimary FocusFunding Provision
H.R. 6311 (CARE Act)Direct funding for treatment and recovery infrastructure✅ Yes
H.R. 679 (Effective Drug Control Safety Act)Evaluate drug control program effectiveness❌ No
H.R. 4275 (Empowering Pharmacists Act)Expanding pharmacist engagement in opioid response❌ No
H.R. 5812 (CONNECTIONS Act)Enhance opioid navigation services❌ No
H.R. 5327 (Opioid Recovery Centers Act)Establish recovery centers❌ No

While these bills address critical aspects of the opioid crisis, none provide direct and sustained funding like H.R. 6311 does.

Effectiveness

How effective are current and proposed legislations?

Most previous legislative efforts have laid the groundwork for combating substance abuse but fall short in funding. The CARE Act is positioned as a more impactful measure by offering tangible financial resources to support education, treatment accessibility, staffing improvements, and community outreach. According to Gross and Gordon (2019), engaging policymakers is a vital step in making progress against addiction—a goal that the CARE Act effectively addresses by aligning government resources with on-the-ground needs.

Diverse Clientele

Does the policy address various substance use disorders?

Yes. Though primarily aimed at opioids, the CARE Act also addresses stimulants, alcohol, and other addictive substances. It supports locally-driven efforts to expand access to evidence-based treatment regardless of the substance involved. According to CADCA (2021), the bill’s comprehensive approach allows providers to tailor interventions based on the specific needs of their populations, including those dealing with methamphetamine, alcohol, or even cannabis misuse.

Urgency

Why is immediate action necessary?

The United States continues to face a worsening opioid epidemic, with over 33,000 annual deaths from both prescription and illicit opioids (Soelberg et al., n.d.). Every day of delay results in more preventable fatalities. The urgency is not just statistical; it’s deeply personal—affecting families and communities nationwide. The CARE Act is a necessary response to mitigate this crisis through education, recovery services, and resource allocation.

Position

What is Mile High Behavioral Healthcare’s position?

MHBHC supports the passage of H.R. 6311. As a service provider catering to clients struggling with addiction and co-occurring conditions, they recognize the transformative potential of financial assistance in expanding operations. Funding from the bill could help address staff shortages, client housing instability, and inpatient care costs, especially for those without insurance or income.

Advantages and Disadvantages

What are the pros and cons of the bill?

AdvantagesDisadvantages
Provides large-scale, long-term fundingFunding is distributed over ten years, delaying immediate impact
Improves access to inpatient/outpatient treatmentFocus is mainly on opioids and stimulants, leaving out other substances like alcohol
Increases staffing capacity and essential servicesSmaller or rural communities may be overlooked in the funding allocation process
Expands access for uninsured and low-income individuals 

Diversity Considerations

What diversity and equity challenges may arise?

Cultural and socioeconomic disparities could affect equitable access to the CARE Act’s benefits. Rural and small communities may be overlooked due to lower population statistics, even though need may be substantial. Homeless populations, particularly vulnerable to substance use, might not be reflected in formal data due to underreporting. Additionally, the bill does not fully address alcohol and cannabis use disorders, both of which significantly impact public health (Krantz, 2022; McCarty et al., n.d.).

Legal and Ethical Matters

Are there potential legal or ethical concerns?

There are no direct legal or ethical violations associated with the CARE Act. However, organizations implementing the bill, such as MHBHC, must strictly adhere to the Ethical Standards for Human Services Professionals. With increased funding and staff, the risk of ethical lapses may rise if new hires are not properly vetted and trained. Ensuring continuous ethics training and oversight is essential.

Redesign Recommendations

How could the bill be improved?

  • Expand coverage to include alcohol and marijuana addiction
  • Prioritize funding based on poverty and homelessness rates, not just overdose statistics
  • Ensure equitable allocation to smaller and underserved areas
  • Broaden the scope to all states, irrespective of severity metrics

These adjustments would promote inclusivity and fairness in addressing America’s addiction crisis.

Responsibilities

Who is responsible for implementation?

ResponsibilityEntity
Bill drafting and approvalU.S. Congress
Federal fund allocationDepartment of Health and Human Services (HHS)
Local implementationState Departments of Revenue and Behavioral Health
Service deliveryLocal nonprofit organizations like MHBHC

States are responsible for distributing the received funds to qualifying organizations, prioritizing need and impact.

Beneficiaries

Who benefits from the CARE Act?

Mile High Behavioral Healthcare, among other treatment providers, stands to benefit significantly. Though the bill is not yet law, MHBHC would likely be eligible to apply for funding once it passes. There is no public opposition from key stakeholders, further highlighting its potential acceptance and effectiveness.

Other Groups

Numerous other behavioral health organizations, hospitals, and addiction centers across the country support H.R. 6311. Many congressional representatives, including Diana DeGette (CO) and Jerrold Nadler (NY), have co-sponsored the bill, indicating widespread political support (GovTrack, 2021).

Strategies

What strategies are needed for national support?

To raise public awareness and build support for H.R. 6311, the following advocacy strategies should be implemented:

POLI 330N Cover Letter – Week 7 Assignment: Final Project – Policy Issue

StrategyPurpose
Town halls and ralliesEducate the public on local addiction issues
Media campaignsRaise national awareness
Community partnershipsMobilize grassroots support
Legislative lobbyingEngage lawmakers for co-sponsorship

Outreach and education are essential to ensure widespread backing and eventual passage.

References

Soelberg, C. D., Brown, R. E., Du Vivier, D., Meyer, J. E., & Ramachandran, B. K. (n.d.). The US opioid crisis: Legal issueshttps://pubmed.ncbi.nlm.nih.gov/29049113

CADCA. (2021). Comprehensive Addiction Resources Emergency (CARE) Acthttps://cadca.org/comprehensive-addictionand-recovery-act-cara

CDHS. (2022). Opioid crisis in Coloradohttps://cdhs.colorado.gov/behavioral-health/opioid-crisis

Congress.gov. (2022). H.R.6311 – 117th Congress (2021-2022)https://www.congress.gov/bill/117th-congress/house-bill/6311

Congress.gov. (2022). H.R.679 – 117th Congress (2021-2022)https://www.congress.gov/bill/117th-congress/house-bill/679

POLI 330N Cover Letter – Week 7 Assignment: Final Project – Policy Issue

GovTrack. (2021). H.R. 6311 Cosponsorshttps://www.govtrack.us/congress/bills/117/hr6311/cosponsors

Gross, J., & Gordon, D. B. (2019). The strengths and weaknesses of current US policy to address pain. American Journal of Public Health, 109(1), 66–72. https://doi.org/10.2105/AJPH.2018.304746

Krantz, B. (2022). Alcohol is killing more people than opioids. Caron Treatment Centers. https://www.caron.org/blog/alcohol-is-killing-more-people-than-the-opioid-epidemic

McCarty, D., Argeriou, M., Huebner, R. B., & Lubran, B. (n.d.). Alcoholism, drug abuse, and the homelesshttps://pubmed.ncbi.nlm.nih.gov/1772151

MHBC. (n.d.). Vision, Mission, Valueshttps://www.milehighbehavioralhealthcare.org/vision-mission-values

Leave a Reply

Your email address will not be published. Required fields are marked *.

*
*